Aptamer Group opens £0.5m retail offer alongside £4.3m placing

Aptamer Group Plc ( (GB:APTA) ) has issued an announcement.

Aptamer Group has launched a retail share offer via the BookBuild platform to raise up to £0.5 million by issuing as many as 83,333,333 new shares at 0.6 pence each to existing UK shareholders, with one transferable warrant granted for every three shares subscribed. The offer, which complements but is separate from a £4.275 million placing and subscription already conditionally secured, is intended to broaden participation among retail investors, provide additional growth capital on the same terms as institutional backers, and potentially offers EIS eligibility pending legislative changes, with completion subject to shareholder approval and AIM admission in April.

The most recent analyst rating on (GB:APTA) stock is a Sell with a £0.62 price target. To see the full list of analyst forecasts on Aptamer Group Plc stock, see the GB:APTA Stock Forecast page.

Spark’s Take on APTA Stock

According to Spark, TipRanks’ AI Analyst, APTA is a Underperform.

The score is primarily held down by very weak financial performance (sharp revenue collapse, continued losses, and negative cash flows). Technical indicators also remain bearish with the stock below major moving averages and negative MACD; oversold momentum readings provide only limited support. Valuation is constrained by a negative P/E and no dividend data.

To see Spark’s full report on APTA stock, click here.

More about Aptamer Group Plc

Aptamer Group plc is a UK-based life sciences company specialising in next-generation synthetic binders for research, diagnostics and therapeutics. Listed on AIM under the ticker APTA, the group targets innovation-led customers across the life science industry, supplying bespoke affinity reagents as an alternative to traditional antibodies.

Average Trading Volume: 4,829,999

Technical Sentiment Signal: Sell

Current Market Cap: £16.86M

Learn more about APTA stock on TipRanks’ Stock Analysis page.